Preprint · CC-BY via OpenAlex

Semaglutide reduces proteomic organ-specific biological age across randomized clinical trials

Maria Dermit, Helen M Colhoun, Ludger J.E. Goeminne, D H Ryan, Kasper Adelborg, Dylan M. Belmont-Rausch, Kristoffer Jensen Kolnes, Filip Krag Knop, Sarah Amandine Caroline Voisin, Vadim N. Gladyshev, LOTTE BJERRE KNUDSEN, Alejandro Aguayo‐Orozco

Research Square · 2026

Loss of proteostasis Human

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.21203/rs.3.rs-11082091/v1
Canonical: link ↗
Fetched: 2026-10-14 MST

Cite this

APA

Dermit, M., Colhoun, H.M., Goeminne, L.J., Ryan, D.H., Adelborg, K., Belmont-Rausch, D.M., Kolnes, K.J., Knop, F.K., Voisin, S.A.C., Gladyshev, V.N., KNUDSEN, L.B., & Aguayo‐Orozco, A. (2026). Semaglutide reduces proteomic organ-specific biological age across randomized clinical trials. <em>Research Square</em>. https://doi.org/10.21203/rs.3.rs-11082091/v1

Vancouver

Dermit M, Colhoun HM, Goeminne LJ, Ryan DH, Adelborg K, Belmont-Rausch DM, et al. Semaglutide reduces proteomic organ-specific biological age across randomized clinical trials. Research Square. 2026. doi:10.21203/rs.3.rs-11082091/v1.

BibTeX

@unpublished{maria2026Semagl, title = {Semaglutide reduces proteomic organ-specific biological age across randomized clinical trials}, author = {Maria Dermit and Helen M Colhoun and Ludger J.E. Goeminne and D H Ryan and Kasper Adelborg and Dylan M. Belmont-Rausch and Kristoffer Jensen Kolnes and Filip Krag Knop and Sarah Amandine Caroline Voisin and Vadim N. Gladyshev and LOTTE BJERRE KNUDSEN and Alejandro Aguayo‐Orozco}, journal = {Research Square}, year = {2026}, doi = {10.21203/rs.3.rs-11082091/v1}, }